Novo Nordisk announced new data that suggests their experimental CagriSema injection can help people lose weight, potentially improving upon its existing blockbuster GLP-1 drug Wegovy.
מקור: Business News — לכתבה המלאה
novo's next-generation obesity drug shows 25% weight loss in women in late-stage analysis
כתיבת תגובה